Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Expert Consensus on Biological Treatments in Psoriasis

In an expert consensus, dermatologists and hospital pharmacists agreed that it is important to use standardized measures in the evaluation of biological treatment maintenance over time in moderate-to-severe psoriasis. The study explored the scientific opinion of a panel of dermatologists and hospital pharmacists to reach a consensus about the impact, causes, best strategies and interventions that may be associated with improved drug persistence in patients with psoriasis in Spain. The research was conducted using a modified Delphi method organized in 2 rounds and involving a panel of 90 dermatologists and 34 hospital pharmacists. A questionnaire with 70 items was developed. Among the findings:

  • Dermatologists reached a consensus on 77.1% of the items proposed, while hospital pharmacists reached a consensus on 71.4%.
  • Both groups agreed that it is important to use standardized measures in the evaluation of treatment maintenance over time.
  • Dermatologists agreed that treatment survival, persistence and retention are synonymous, but hospital pharmacists considered only treatment persistence as a valid term.

Citation:

de la Cueva Dobao P, Notario J, Ferrándiz C, et al. Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis. [Published online ahead of print April 29, 2019]. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.15600.